Performance of urinalysis tests in screening for significant bacteriuria
Beuy Joob1, Viroj Wiwanitkit2
1 Sanitation 1 Medical Academic Center, Bangkok, Thailand
2 Department of Community Medicine, Dr. DY Patil University, Mumbai, Maharashtra, India
|Date of Web Publication||26-Dec-2017|
Dr. Beuy Joob
Sanitation 1 Medical Academic Center, Bangkok
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Joob B, Wiwanitkit V. Performance of urinalysis tests in screening for significant bacteriuria. J Res Med Sci 2017;22:129
Dear Editor, the report on “Performance of urinalysis tests in screening for significant bacteriuria is very interesting.” Vignesh et al. concluded that “the results of rapid dipstick urinalysis tests might not be sufficient enough to replace the conventional urine culture method, and the clinical decision is to be made only based on the culture and sensitivity results among the HIV-infected patients.” Indeed, this result can be expected since the basic investigation technique for any dipstick test is dry biochemistry which cannot replace the gold standard technique of microscopic and microbiological tests. In a recent report, it is noted that the use of nonstandard technique for urinalysis test aiming at the diagnosis of infection is very common and becomes a big problem in clinical general practice. Nevertheless, the use of dipstick test might still be useful in large-scale primary screening. The confirmation for positive case by standard referencing technique is the next step.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Vignesh R, Swathirajan CR, Solomon SS, Solomon S, Balakrishnan P. Performance of urinalysis tests in screening for significant bacteriuria among human immunodeficiency virus-infected subjects in South India. J Res Med Sci 2017;22:77.
] [Full text]
Kinouani S, de Lary de Latour H, Joseph JP, Letrilliart L. Diagnostic strategies for urinary tract infections in French general practice. Med Mal Infect 2017. pii: S0399-077X(17) 30637-6.